The research compound in Xenical®
Xenical® is a obesity management medicine from Roche. Its active compound is Orlistat — which is what this catalogue supplies, as a research material.
This is not Xenical®, and NOVALYTE LABS has no affiliation with Roche. We supply the compound Orlistat for laboratory research only — not for human consumption, diagnostic, therapeutic or veterinary use. Xenical® is a trademark of Roche, referenced here only to identify the compound.
Xenical is Roche’s brand for orlistat; a lower-dose version is sold over the counter as Alli.
Orlistat is mechanistically unlike everything else in this category: it does not act on appetite signalling at all, but inhibits pancreatic lipase in the gut lumen, reducing dietary fat absorption. Its action is local rather than systemic.
Orlistat is supplied here as a research material, not as the branded medicine.
Orlistat in this catalogue
120mg oral tablets
How Orlistat is supplied here
Everything below describes the research material in this catalogue, not the medicine.
| Compound | Orlistat |
|---|---|
| Presentation | 120mg oral tablets |
| Dosage options | 120mg |
| Research category | Metabolic Research |
| Batch COA | Certificate supplied with order |
| Availability | In stock |
| Intended use | Laboratory research only — not for human or veterinary use |
Common questions
What is the active compound in Xenical?
Orlistat. Xenical is a registered trademark of Roche, approved for obesity management.
Is this Xenical?
No. NOVALYTE LABS supplies Orlistat as a research material with batch documentation. It is not Xenical, it is not a medicine, it is not supplied for human use, and there is no affiliation with Roche.
Why is Orlistat sold under more than one brand?
Because a brand is tied to an approved indication rather than to the molecule. Orlistat is marketed as Xenical and also as Alli — same compound, different approvals.
Other brands using Orlistat
The same compound is marketed under more than one brand, usually because each brand carries a different approved indication.